Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
Sectoral · Direct Growth Very High Risk
₹24.6135
NAV on 28-Oct-2026
Showing the Direct plan. The Regular plan you picked has the same portfolio but a higher expense ratio, so its NAV and returns are lower.
Fund size (AUM)
₹192 Cr
Expense ratio
0.56%
Since inception (CAGR)
+16.00%
Minimum SIP · lump sum
₹100 · ₹100
Returns
absolute up to 1Y, annualised beyond| 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|---|
| This fund | -1.08% | 0.00% | +14.77% | +16.24% | +20.89% | +14.14% | — |
| Category average | — | -4.89% | +7.29% | +6.47% | +20.21% | +14.60% | — |
About
| Fund house | Edelweiss Mutual Fund |
| Fund managers | Hardik Verma |
| Benchmark | MSCI India Domestic & World Healthcare 45 Index |
| Launched | 26-Oct-2020 |
| ISIN | INF754K01LV5 |
| Exit load | — |
Risk
| Standard deviation | 12.54 |
| Sharpe ratio | 1.00 |
| Sortino ratio | 1.99 |
| Alpha | 2.23 |
| Beta | 0.68 |
Top holdings
48 in total| Holding | Sector | Value | % of fund |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | ₹20 Cr | 10.45% |
| Divi's Laboratories Ltd | Healthcare | ₹14 Cr | 7.09% |
| Eli Lilly Forgn. Eq (LLY) | Healthcare | ₹12 Cr | 6.46% |
| Apollo Hospitals Enterprise Ltd | Healthcare | ₹10 Cr | 5.25% |
| Johnson & Johnson Ltd. Forgn. Eq (JNJ) | Healthcare | ₹9 Cr | 4.45% |
| Laurus Labs Ltd | Healthcare | ₹9 Cr | 4.44% |
| Torrent Pharmaceuticals Ltd | Healthcare | ₹8 Cr | 4.38% |
| Cipla Ltd | Healthcare | ₹8 Cr | 4.34% |
| Max Healthcare Institute Ltd | Healthcare | ₹8 Cr | 4.19% |
| Dr. Reddy's Laboratories Ltd | Healthcare | ₹8 Cr | 3.95% |
| AbbVie Inc Forgn. Eq (ABBV) | Healthcare | ₹6 Cr | 3.22% |
| Lupin Ltd | Healthcare | ₹6 Cr | 2.97% |
| Aurobindo Pharma Ltd | Healthcare | ₹5 Cr | 2.77% |
| Merck & Co Inc (US) Forgn. Eq (MRK) | Healthcare | ₹5 Cr | 2.50% |
| Fortis Healthcare Ltd | Healthcare | ₹5 Cr | 2.41% |
| Glenmark Pharmaceuticals Ltd | Healthcare | ₹4 Cr | 2.11% |
| Novartis AG ADS/ADR (NVS) | Healthcare | ₹3 Cr | 1.82% |
| Thermo Fisher Scientific Inc Forgn. Eq (TMO) | Healthcare | ₹3 Cr | 1.75% |
| Ipca Laboratories Ltd | Healthcare | ₹3 Cr | 1.72% |
| Mankind Pharma Ltd. | Healthcare | ₹3 Cr | 1.65% |
Fetched 29 Oct, 17:42 IST. Past returns don't predict future returns. Source: Indian Stock API.